Cecilia Furlong
Stock Analyst at Morgan Stanley
(0.8)
# 2145
Out of 5,329 analysts
207
Total ratings
46.38%
Success rate
-6.73%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NVRO Nevro | Downgrades: Underweight | 9 4 | n/a | n/a | 9 | Dec 2, 2024 | |
ISRG Intuitive Surgical | Upgrades: Overweight | 522 650 | 530.39 | 22.55% | 13 | Dec 2, 2024 | |
SGHT Sight Sciences | Maintains: Equal-Weight | 7 5 | 3.21 | 55.76% | 15 | Nov 11, 2024 | |
EMBC Embecta | Maintains: Underweight | 13 12 | 12.57 | -4.53% | 12 | Jul 15, 2024 | |
IRTC iRhythm Technologies | Maintains: Overweight | 135 130 | 131.59 | -1.21% | 15 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 130 120 | 101.72 | 17.97% | 11 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 95 | 89.96 | 5.6% | 12 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 98 | 84.35 | 16.18% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 76 69 | n/a | n/a | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 83 83 | n/a | n/a | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 78 85 | 98.5 | -13.71% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 224 291 | n/a | n/a | 6 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 15 | 23.32 | -35.68% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 325 343 | 256.43 | 33.76% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 14 | 3.81 | 267.45% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 48 | 30.59 | 56.91% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 102 | 75.67 | 34.8% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 58 | 104.83 | -44.67% | 16 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 20 | 11.78 | 69.78% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 117 131 | 81.2 | 61.33% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 132.15 | 0.64% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 235 380 | n/a | n/a | 2 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 270 220 | 377.04 | -41.65% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 383 378 | 126.53 | 198.74% | 2 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 29 25 | n/a | n/a | 3 | Jan 7, 2022 |